169 related articles for article (PubMed ID: 11119897)
1. Japanese single-center experience of kidney transplantation under tacrolimus immunosuppression.
Tanabe K; Tokumoto T; Ishikawa N; Shimizu T; Okuda H; Ito S; Shimmura H; Inui M; Harano M; Manu M; Koga S; Ohtsubo S; Suzuki K; Shiroyanagi Y; Goya N; Nakazawa H; Yagisawa T; Nakajima I; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1696-9. PubMed ID: 11119897
[No Abstract] [Full Text] [Related]
2. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Kanematsu A; Kitani R; Fuchinoue S; Oshima T; Yagisawa T; Toma H
Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497
[No Abstract] [Full Text] [Related]
3. Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
Suzuki K; Tanabe K; Tokumoto T; Shimizu T; Ishikawa N; Yagisawa T; Honda K; Nihei H; Toma H
Transplant Proc; 2000 Nov; 32(7):1730-2. PubMed ID: 11119910
[No Abstract] [Full Text] [Related]
4. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
[No Abstract] [Full Text] [Related]
5. Malabsorption of tacrolimus in kidney transplant recipients: a Japanese single center experience.
Tanabe K; Tokumoto T; Ishikawa N; Shimizu T; Okuda H; Ito S; Shinmura H; Inui M; Harano M; Manu M; Koga S; Shiroyanagi Y; Goya N; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1718-20. PubMed ID: 11119906
[No Abstract] [Full Text] [Related]
6. Long-term stable glomerular filtration rate achieved with tacrolimus in pediatric renal transplantation.
Pape L; Henne T; Strehlau J; Latta K; Ehrich JH; Offner G
Transplant Proc; 2002 Sep; 34(6):2211-2. PubMed ID: 12270367
[No Abstract] [Full Text] [Related]
7. Successful results after 3 years' tacrolimus immunosuppression in ABO-incompatible kidney transplantation recipients in Japan.
Takahashi K; Takahara S; Uchida K; Oshima S; Toma H; Sonoda T;
Transplant Proc; 2002 Aug; 34(5):1604-5. PubMed ID: 12176502
[No Abstract] [Full Text] [Related]
8. How to handle mycophenolate mofetil in combination with tacrolimus?
Braun F; Canelo R; Schütz E; Shipkora M; Lorf T; Hanack U; Niedmann D; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 1998 Dec; 30(8):4094-5. PubMed ID: 9865309
[No Abstract] [Full Text] [Related]
9. Tacrolimus therapy for ABO-incompatible kidney transplantation.
Takahashi K; Saito K; Sonda K; Nakagawa Y; Katagiri A; Tomita Y; Tanigawa T; Takeda M
Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
[No Abstract] [Full Text] [Related]
10. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
[No Abstract] [Full Text] [Related]
11. Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single Japanese center.
Okamoto M; Omori Y; Kadotani Y; Ushigome H; Nakamura K; Akioka K; Yoshimura N
Transplant Proc; 2002 Aug; 34(5):1666. PubMed ID: 12176527
[No Abstract] [Full Text] [Related]
12. Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.
Braun F; Schütz E; Peters B; Talaulicar R; Grupp C; Undre N; Schäfer A; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 2001 May; 33(3):2127-8. PubMed ID: 11377473
[No Abstract] [Full Text] [Related]
13. Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center.
Schneeberger H; Zanker B; Hillebrand G; Illner WD; Rothenpieler U; Land W
Transplant Proc; 1998 Jun; 30(4):1598-9. PubMed ID: 9636642
[No Abstract] [Full Text] [Related]
14. Excellent 3-year results following living-donor kidney transplantation and tacrolimus immunosuppression in Japan.
Uchida K; Takahashi K; Takahara S; Oshima S; Toma H; Sonoda T;
Transplant Proc; 2002 Aug; 34(5):1606-7. PubMed ID: 12176503
[No Abstract] [Full Text] [Related]
15. Outcome of kidney transplantation from non-heart-beating donors followed by tacrolimus immunosuppression in japan.
Tanabe K; Takahashi K; Takahara S; Uchida K; Oshima S; Toma H; Sonoda T;
Transplant Proc; 2002 Aug; 34(5):1580-2. PubMed ID: 12176493
[No Abstract] [Full Text] [Related]
16. Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience.
Lye WC
Transplant Proc; 2000 Nov; 32(7):1700-1. PubMed ID: 11119898
[No Abstract] [Full Text] [Related]
17. Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection.
Naraghi RM; Smith D; Shapiro R; Vivas CA; Gritsch HA; Scantlebury VP; McCauley J; Randhawa P; Demetris AJ; McMichael J; Fung JJ; Starzl TE; Jordan ML
Transplant Proc; 1997; 29(1-2):310. PubMed ID: 9123013
[No Abstract] [Full Text] [Related]
18. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
[No Abstract] [Full Text] [Related]
19. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
[No Abstract] [Full Text] [Related]
20. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.
Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K
Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498
[No Abstract] [Full Text] [Related]
[Next] [New Search]
